NCT02432092Recruiting
Pediatric Cardiomyopathy Mutation Analysis
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 28 Apr 2015
- Start date
- 1 Apr 2014
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Indiana University
- Diseases
- Heart failure, Hypertrophic cardiomyopathy
- NCT number
- NCT02432092
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Apr 2014 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subjects without cardiomyopathy
- Family members of subjects without cardiomyopathy
Who the study is looking for
- Subjects with cardiomyopathy
- Family members of subjects with cardiomyopathy
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IU School of Medicine Coordinator of this site? Confirm its status | Indianapolis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.